Popular heartburn medication Zantac recalled in U.S., but not yet in Canada

The U.S. Food and Drug Administration announced Wednesday that it is asking manufacturers and pharmacies to cease production and sale of over-the-counter Zantac, a medication that treats heartburn, due to potential contamination. According to the FDA, the medication could contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA). An investigation into the levels of NDMA within ranitidine medication has been ongoing since the summer of 2019, when laboratory testing found NDMA in ranitid